Thin Film Drugs Industry Research Report 2024
Thin-film drug delivery uses a dissolving film or oral drug strip to administer drugs via absorption in the mouth and/or via the small intestines. A film is prepared using hydrophilic polymers that rapidly dissolves on the tongue or buccal cavity, delivering the drug to the systemic circulation via dissolution when contact with liquid is made.
According to APO Research, The global Thin Film Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
Global Thin Film Drugs key players include GSK, LTS, J&J, Indivior, Pfizer, etc. Global top five manufacturers hold a share over 35%.
Europe is the largest market, with a share about 40%, followed by Asia-Pacific, and North America, both have a share about 45 percent.
In terms of product, Transdermal Film is the largest segment, with a share over 70%. And in terms of application, the largest application is Drugstores, followed by Hospitals, etc.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Thin Film Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Thin Film Drugs.
The Thin Film Drugs market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Thin Film Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Thin Film Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Thin Film Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Thin Film Drugs.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Thin Film Drugs companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
Chapter 13: The main points and conclusions of the report.
According to APO Research, The global Thin Film Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
Global Thin Film Drugs key players include GSK, LTS, J&J, Indivior, Pfizer, etc. Global top five manufacturers hold a share over 35%.
Europe is the largest market, with a share about 40%, followed by Asia-Pacific, and North America, both have a share about 45 percent.
In terms of product, Transdermal Film is the largest segment, with a share over 70%. And in terms of application, the largest application is Drugstores, followed by Hospitals, etc.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Thin Film Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Thin Film Drugs.
The Thin Film Drugs market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Thin Film Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
- GSK
- LTS
- J&J
- Indivior
- Pfizer
- Sanofi
- Church & Dwight
- tesa Labtec
- Tapemark
- Prestige Bands
- Sun Pharma
- MonoSol
- BioDelivery
- Arx
- ZIM
- NAL Pharma
- AdhexPharma
- Aavishkar
- IntelGenx Corp
- APR
- Transdermal Film
- Oral Thin Film
- Others
- Hospitals
- Drugstores
- Others
- North America
- United States
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Nordic Countries
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Thin Film Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Thin Film Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Thin Film Drugs.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Thin Film Drugs companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
Chapter 13: The main points and conclusions of the report.
1 PREFACE
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 MARKET OVERVIEW
2.1 Product Definition
2.2 Thin Film Drugs by Type
2.2.1 Market Value Comparison by Type (2019 VS 2023 VS 2030)
2.2.2 Transdermal Film
2.2.3 Oral Thin Film
2.2.4 Others
2.3 Thin Film Drugs by Application
2.3.1 Market Value Comparison by Application (2019 VS 2023 VS 2030)
2.3.2 Hospitals
2.3.3 Drugstores
2.3.4 Others
2.4 Assumptions and Limitations
3 THIN FILM DRUGS BREAKDOWN DATA BY TYPE
3.1 Global Thin Film Drugs Historic Market Size by Type (2019-2024)
3.2 Global Thin Film Drugs Forecasted Market Size by Type (2025-2030)
4 THIN FILM DRUGS BREAKDOWN DATA BY APPLICATION
4.1 Global Thin Film Drugs Historic Market Size by Application (2019-2024)
4.2 Global Thin Film Drugs Forecasted Market Size by Application (2019-2024)
5 GLOBAL GROWTH TRENDS
5.1 Global Thin Film Drugs Market Perspective (2019-2030)
5.2 Global Thin Film Drugs Growth Trends by Region
5.2.1 Global Thin Film Drugs Market Size by Region: 2019 VS 2023 VS 2030
5.2.2 Thin Film Drugs Historic Market Size by Region (2019-2024)
5.2.3 Thin Film Drugs Forecasted Market Size by Region (2025-2030)
5.3 Thin Film Drugs Market Dynamics
5.3.1 Thin Film Drugs Industry Trends
5.3.2 Thin Film Drugs Market Drivers
5.3.3 Thin Film Drugs Market Challenges
5.3.4 Thin Film Drugs Market Restraints
6 MARKET COMPETITIVE LANDSCAPE BY PLAYERS
6.1 Global Top Thin Film Drugs Players by Revenue
6.1.1 Global Top Thin Film Drugs Players by Revenue (2019-2024)
6.1.2 Global Thin Film Drugs Revenue Market Share by Players (2019-2024)
6.2 Global Thin Film Drugs Industry Players Ranking, 2022 VS 2023 VS 2024
6.3 Global Key Players of Thin Film Drugs Head office and Area Served
6.4 Global Thin Film Drugs Players, Product Type & Application
6.5 Global Thin Film Drugs Players, Date of Enter into This Industry
6.6 Global Thin Film Drugs Market CR5 and HHI
6.7 Global Players Mergers & Acquisition
7 NORTH AMERICA
7.1 North America Thin Film Drugs Market Size (2019-2030)
7.2 North America Thin Film Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 North America Thin Film Drugs Market Size by Country (2019-2024)
7.4 North America Thin Film Drugs Market Size by Country (2025-2030)
7.5 United States
7.6 Canada
8 EUROPE
8.1 Europe Thin Film Drugs Market Size (2019-2030)
8.2 Europe Thin Film Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Europe Thin Film Drugs Market Size by Country (2019-2024)
8.4 Europe Thin Film Drugs Market Size by Country (2025-2030)
8.5 Germany
8.6 France
8.7 U.K.
8.8 Italy
8.9 Russia
8.10 Nordic Countries
9 ASIA-PACIFIC
9.1 Asia-Pacific Thin Film Drugs Market Size (2019-2030)
9.2 Asia-Pacific Thin Film Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Asia-Pacific Thin Film Drugs Market Size by Country (2019-2024)
9.4 Asia-Pacific Thin Film Drugs Market Size by Country (2025-2030)
9.5 China
9.6 Japan
9.7 South Korea
9.8 Southeast Asia
9.9 India
9.10 Australia
10 LATIN AMERICA
10.1 Latin America Thin Film Drugs Market Size (2019-2030)
10.2 Latin America Thin Film Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Latin America Thin Film Drugs Market Size by Country (2019-2024)
10.4 Latin America Thin Film Drugs Market Size by Country (2025-2030)
10.5 Mexico
10.6 Brazil
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Thin Film Drugs Market Size (2019-2030)
11.2 Middle East & Africa Thin Film Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
11.3 Middle East & Africa Thin Film Drugs Market Size by Country (2019-2024)
11.4 Middle East & Africa Thin Film Drugs Market Size by Country (2025-2030)
11.5 Turkey
11.6 Saudi Arabia
11.7 UAE
12 PLAYERS PROFILED
12.1 GSK
12.1.1 GSK Company Information
12.1.2 GSK Business Overview
12.1.3 GSK Revenue in Thin Film Drugs Business (2019-2024)
12.1.4 GSK Thin Film Drugs Product Portfolio
12.1.5 GSK Recent Developments
12.2 LTS
12.2.1 LTS Company Information
12.2.2 LTS Business Overview
12.2.3 LTS Revenue in Thin Film Drugs Business (2019-2024)
12.2.4 LTS Thin Film Drugs Product Portfolio
12.2.5 LTS Recent Developments
12.3 J&J
12.3.1 J&J Company Information
12.3.2 J&J Business Overview
12.3.3 J&J Revenue in Thin Film Drugs Business (2019-2024)
12.3.4 J&J Thin Film Drugs Product Portfolio
12.3.5 J&J Recent Developments
12.4 Indivior
12.4.1 Indivior Company Information
12.4.2 Indivior Business Overview
12.4.3 Indivior Revenue in Thin Film Drugs Business (2019-2024)
12.4.4 Indivior Thin Film Drugs Product Portfolio
12.4.5 Indivior Recent Developments
12.5 Pfizer
12.5.1 Pfizer Company Information
12.5.2 Pfizer Business Overview
12.5.3 Pfizer Revenue in Thin Film Drugs Business (2019-2024)
12.5.4 Pfizer Thin Film Drugs Product Portfolio
12.5.5 Pfizer Recent Developments
12.6 Sanofi
12.6.1 Sanofi Company Information
12.6.2 Sanofi Business Overview
12.6.3 Sanofi Revenue in Thin Film Drugs Business (2019-2024)
12.6.4 Sanofi Thin Film Drugs Product Portfolio
12.6.5 Sanofi Recent Developments
12.7 Church & Dwight
12.7.1 Church & Dwight Company Information
12.7.2 Church & Dwight Business Overview
12.7.3 Church & Dwight Revenue in Thin Film Drugs Business (2019-2024)
12.7.4 Church & Dwight Thin Film Drugs Product Portfolio
12.7.5 Church & Dwight Recent Developments
12.8 tesa Labtec
12.8.1 tesa Labtec Company Information
12.8.2 tesa Labtec Business Overview
12.8.3 tesa Labtec Revenue in Thin Film Drugs Business (2019-2024)
12.8.4 tesa Labtec Thin Film Drugs Product Portfolio
12.8.5 tesa Labtec Recent Developments
12.9 Tapemark
12.9.1 Tapemark Company Information
12.9.2 Tapemark Business Overview
12.9.3 Tapemark Revenue in Thin Film Drugs Business (2019-2024)
12.9.4 Tapemark Thin Film Drugs Product Portfolio
12.9.5 Tapemark Recent Developments
12.10 Prestige Bands
12.10.1 Prestige Bands Company Information
12.10.2 Prestige Bands Business Overview
12.10.3 Prestige Bands Revenue in Thin Film Drugs Business (2019-2024)
12.10.4 Prestige Bands Thin Film Drugs Product Portfolio
12.10.5 Prestige Bands Recent Developments
12.11 Sun Pharma
12.11.1 Sun Pharma Company Information
12.11.2 Sun Pharma Business Overview
12.11.3 Sun Pharma Revenue in Thin Film Drugs Business (2019-2024)
12.11.4 Sun Pharma Thin Film Drugs Product Portfolio
12.11.5 Sun Pharma Recent Developments
12.12 MonoSol
12.12.1 MonoSol Company Information
12.12.2 MonoSol Business Overview
12.12.3 MonoSol Revenue in Thin Film Drugs Business (2019-2024)
12.12.4 MonoSol Thin Film Drugs Product Portfolio
12.12.5 MonoSol Recent Developments
12.13 BioDelivery
12.13.1 BioDelivery Company Information
12.13.2 BioDelivery Business Overview
12.13.3 BioDelivery Revenue in Thin Film Drugs Business (2019-2024)
12.13.4 BioDelivery Thin Film Drugs Product Portfolio
12.13.5 BioDelivery Recent Developments
12.14 Arx
12.14.1 Arx Company Information
12.14.2 Arx Business Overview
12.14.3 Arx Revenue in Thin Film Drugs Business (2019-2024)
12.14.4 Arx Thin Film Drugs Product Portfolio
12.14.5 Arx Recent Developments
12.15 ZIM
12.15.1 ZIM Company Information
12.15.2 ZIM Business Overview
12.15.3 ZIM Revenue in Thin Film Drugs Business (2019-2024)
12.15.4 ZIM Thin Film Drugs Product Portfolio
12.15.5 ZIM Recent Developments
12.16 NAL Pharma
12.16.1 NAL Pharma Company Information
12.16.2 NAL Pharma Business Overview
12.16.3 NAL Pharma Revenue in Thin Film Drugs Business (2019-2024)
12.16.4 NAL Pharma Thin Film Drugs Product Portfolio
12.16.5 NAL Pharma Recent Developments
12.17 AdhexPharma
12.17.1 AdhexPharma Company Information
12.17.2 AdhexPharma Business Overview
12.17.3 AdhexPharma Revenue in Thin Film Drugs Business (2019-2024)
12.17.4 AdhexPharma Thin Film Drugs Product Portfolio
12.17.5 AdhexPharma Recent Developments
12.18 Aavishkar
12.18.1 Aavishkar Company Information
12.18.2 Aavishkar Business Overview
12.18.3 Aavishkar Revenue in Thin Film Drugs Business (2019-2024)
12.18.4 Aavishkar Thin Film Drugs Product Portfolio
12.18.5 Aavishkar Recent Developments
12.19 IntelGenx Corp
12.19.1 IntelGenx Corp Company Information
12.19.2 IntelGenx Corp Business Overview
12.19.3 IntelGenx Corp Revenue in Thin Film Drugs Business (2019-2024)
12.19.4 IntelGenx Corp Thin Film Drugs Product Portfolio
12.19.5 IntelGenx Corp Recent Developments
12.20 APR
12.20.1 APR Company Information
12.20.2 APR Business Overview
12.20.3 APR Revenue in Thin Film Drugs Business (2019-2024)
12.20.4 APR Thin Film Drugs Product Portfolio
12.20.5 APR Recent Developments
13 REPORT CONCLUSION
14 DISCLAIMER
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 MARKET OVERVIEW
2.1 Product Definition
2.2 Thin Film Drugs by Type
2.2.1 Market Value Comparison by Type (2019 VS 2023 VS 2030)
2.2.2 Transdermal Film
2.2.3 Oral Thin Film
2.2.4 Others
2.3 Thin Film Drugs by Application
2.3.1 Market Value Comparison by Application (2019 VS 2023 VS 2030)
2.3.2 Hospitals
2.3.3 Drugstores
2.3.4 Others
2.4 Assumptions and Limitations
3 THIN FILM DRUGS BREAKDOWN DATA BY TYPE
3.1 Global Thin Film Drugs Historic Market Size by Type (2019-2024)
3.2 Global Thin Film Drugs Forecasted Market Size by Type (2025-2030)
4 THIN FILM DRUGS BREAKDOWN DATA BY APPLICATION
4.1 Global Thin Film Drugs Historic Market Size by Application (2019-2024)
4.2 Global Thin Film Drugs Forecasted Market Size by Application (2019-2024)
5 GLOBAL GROWTH TRENDS
5.1 Global Thin Film Drugs Market Perspective (2019-2030)
5.2 Global Thin Film Drugs Growth Trends by Region
5.2.1 Global Thin Film Drugs Market Size by Region: 2019 VS 2023 VS 2030
5.2.2 Thin Film Drugs Historic Market Size by Region (2019-2024)
5.2.3 Thin Film Drugs Forecasted Market Size by Region (2025-2030)
5.3 Thin Film Drugs Market Dynamics
5.3.1 Thin Film Drugs Industry Trends
5.3.2 Thin Film Drugs Market Drivers
5.3.3 Thin Film Drugs Market Challenges
5.3.4 Thin Film Drugs Market Restraints
6 MARKET COMPETITIVE LANDSCAPE BY PLAYERS
6.1 Global Top Thin Film Drugs Players by Revenue
6.1.1 Global Top Thin Film Drugs Players by Revenue (2019-2024)
6.1.2 Global Thin Film Drugs Revenue Market Share by Players (2019-2024)
6.2 Global Thin Film Drugs Industry Players Ranking, 2022 VS 2023 VS 2024
6.3 Global Key Players of Thin Film Drugs Head office and Area Served
6.4 Global Thin Film Drugs Players, Product Type & Application
6.5 Global Thin Film Drugs Players, Date of Enter into This Industry
6.6 Global Thin Film Drugs Market CR5 and HHI
6.7 Global Players Mergers & Acquisition
7 NORTH AMERICA
7.1 North America Thin Film Drugs Market Size (2019-2030)
7.2 North America Thin Film Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 North America Thin Film Drugs Market Size by Country (2019-2024)
7.4 North America Thin Film Drugs Market Size by Country (2025-2030)
7.5 United States
7.6 Canada
8 EUROPE
8.1 Europe Thin Film Drugs Market Size (2019-2030)
8.2 Europe Thin Film Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Europe Thin Film Drugs Market Size by Country (2019-2024)
8.4 Europe Thin Film Drugs Market Size by Country (2025-2030)
8.5 Germany
8.6 France
8.7 U.K.
8.8 Italy
8.9 Russia
8.10 Nordic Countries
9 ASIA-PACIFIC
9.1 Asia-Pacific Thin Film Drugs Market Size (2019-2030)
9.2 Asia-Pacific Thin Film Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Asia-Pacific Thin Film Drugs Market Size by Country (2019-2024)
9.4 Asia-Pacific Thin Film Drugs Market Size by Country (2025-2030)
9.5 China
9.6 Japan
9.7 South Korea
9.8 Southeast Asia
9.9 India
9.10 Australia
10 LATIN AMERICA
10.1 Latin America Thin Film Drugs Market Size (2019-2030)
10.2 Latin America Thin Film Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Latin America Thin Film Drugs Market Size by Country (2019-2024)
10.4 Latin America Thin Film Drugs Market Size by Country (2025-2030)
10.5 Mexico
10.6 Brazil
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Thin Film Drugs Market Size (2019-2030)
11.2 Middle East & Africa Thin Film Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
11.3 Middle East & Africa Thin Film Drugs Market Size by Country (2019-2024)
11.4 Middle East & Africa Thin Film Drugs Market Size by Country (2025-2030)
11.5 Turkey
11.6 Saudi Arabia
11.7 UAE
12 PLAYERS PROFILED
12.1 GSK
12.1.1 GSK Company Information
12.1.2 GSK Business Overview
12.1.3 GSK Revenue in Thin Film Drugs Business (2019-2024)
12.1.4 GSK Thin Film Drugs Product Portfolio
12.1.5 GSK Recent Developments
12.2 LTS
12.2.1 LTS Company Information
12.2.2 LTS Business Overview
12.2.3 LTS Revenue in Thin Film Drugs Business (2019-2024)
12.2.4 LTS Thin Film Drugs Product Portfolio
12.2.5 LTS Recent Developments
12.3 J&J
12.3.1 J&J Company Information
12.3.2 J&J Business Overview
12.3.3 J&J Revenue in Thin Film Drugs Business (2019-2024)
12.3.4 J&J Thin Film Drugs Product Portfolio
12.3.5 J&J Recent Developments
12.4 Indivior
12.4.1 Indivior Company Information
12.4.2 Indivior Business Overview
12.4.3 Indivior Revenue in Thin Film Drugs Business (2019-2024)
12.4.4 Indivior Thin Film Drugs Product Portfolio
12.4.5 Indivior Recent Developments
12.5 Pfizer
12.5.1 Pfizer Company Information
12.5.2 Pfizer Business Overview
12.5.3 Pfizer Revenue in Thin Film Drugs Business (2019-2024)
12.5.4 Pfizer Thin Film Drugs Product Portfolio
12.5.5 Pfizer Recent Developments
12.6 Sanofi
12.6.1 Sanofi Company Information
12.6.2 Sanofi Business Overview
12.6.3 Sanofi Revenue in Thin Film Drugs Business (2019-2024)
12.6.4 Sanofi Thin Film Drugs Product Portfolio
12.6.5 Sanofi Recent Developments
12.7 Church & Dwight
12.7.1 Church & Dwight Company Information
12.7.2 Church & Dwight Business Overview
12.7.3 Church & Dwight Revenue in Thin Film Drugs Business (2019-2024)
12.7.4 Church & Dwight Thin Film Drugs Product Portfolio
12.7.5 Church & Dwight Recent Developments
12.8 tesa Labtec
12.8.1 tesa Labtec Company Information
12.8.2 tesa Labtec Business Overview
12.8.3 tesa Labtec Revenue in Thin Film Drugs Business (2019-2024)
12.8.4 tesa Labtec Thin Film Drugs Product Portfolio
12.8.5 tesa Labtec Recent Developments
12.9 Tapemark
12.9.1 Tapemark Company Information
12.9.2 Tapemark Business Overview
12.9.3 Tapemark Revenue in Thin Film Drugs Business (2019-2024)
12.9.4 Tapemark Thin Film Drugs Product Portfolio
12.9.5 Tapemark Recent Developments
12.10 Prestige Bands
12.10.1 Prestige Bands Company Information
12.10.2 Prestige Bands Business Overview
12.10.3 Prestige Bands Revenue in Thin Film Drugs Business (2019-2024)
12.10.4 Prestige Bands Thin Film Drugs Product Portfolio
12.10.5 Prestige Bands Recent Developments
12.11 Sun Pharma
12.11.1 Sun Pharma Company Information
12.11.2 Sun Pharma Business Overview
12.11.3 Sun Pharma Revenue in Thin Film Drugs Business (2019-2024)
12.11.4 Sun Pharma Thin Film Drugs Product Portfolio
12.11.5 Sun Pharma Recent Developments
12.12 MonoSol
12.12.1 MonoSol Company Information
12.12.2 MonoSol Business Overview
12.12.3 MonoSol Revenue in Thin Film Drugs Business (2019-2024)
12.12.4 MonoSol Thin Film Drugs Product Portfolio
12.12.5 MonoSol Recent Developments
12.13 BioDelivery
12.13.1 BioDelivery Company Information
12.13.2 BioDelivery Business Overview
12.13.3 BioDelivery Revenue in Thin Film Drugs Business (2019-2024)
12.13.4 BioDelivery Thin Film Drugs Product Portfolio
12.13.5 BioDelivery Recent Developments
12.14 Arx
12.14.1 Arx Company Information
12.14.2 Arx Business Overview
12.14.3 Arx Revenue in Thin Film Drugs Business (2019-2024)
12.14.4 Arx Thin Film Drugs Product Portfolio
12.14.5 Arx Recent Developments
12.15 ZIM
12.15.1 ZIM Company Information
12.15.2 ZIM Business Overview
12.15.3 ZIM Revenue in Thin Film Drugs Business (2019-2024)
12.15.4 ZIM Thin Film Drugs Product Portfolio
12.15.5 ZIM Recent Developments
12.16 NAL Pharma
12.16.1 NAL Pharma Company Information
12.16.2 NAL Pharma Business Overview
12.16.3 NAL Pharma Revenue in Thin Film Drugs Business (2019-2024)
12.16.4 NAL Pharma Thin Film Drugs Product Portfolio
12.16.5 NAL Pharma Recent Developments
12.17 AdhexPharma
12.17.1 AdhexPharma Company Information
12.17.2 AdhexPharma Business Overview
12.17.3 AdhexPharma Revenue in Thin Film Drugs Business (2019-2024)
12.17.4 AdhexPharma Thin Film Drugs Product Portfolio
12.17.5 AdhexPharma Recent Developments
12.18 Aavishkar
12.18.1 Aavishkar Company Information
12.18.2 Aavishkar Business Overview
12.18.3 Aavishkar Revenue in Thin Film Drugs Business (2019-2024)
12.18.4 Aavishkar Thin Film Drugs Product Portfolio
12.18.5 Aavishkar Recent Developments
12.19 IntelGenx Corp
12.19.1 IntelGenx Corp Company Information
12.19.2 IntelGenx Corp Business Overview
12.19.3 IntelGenx Corp Revenue in Thin Film Drugs Business (2019-2024)
12.19.4 IntelGenx Corp Thin Film Drugs Product Portfolio
12.19.5 IntelGenx Corp Recent Developments
12.20 APR
12.20.1 APR Company Information
12.20.2 APR Business Overview
12.20.3 APR Revenue in Thin Film Drugs Business (2019-2024)
12.20.4 APR Thin Film Drugs Product Portfolio
12.20.5 APR Recent Developments
13 REPORT CONCLUSION
14 DISCLAIMER
